Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125632523 | 12563252 | 3 | F | 2015 | 20160927 | 20160715 | 20160928 | EXP | US-PFIZER INC-2016338340 | PFIZER | 59.00 | YR | M | Y | 68.00000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125632523 | 12563252 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20 MG, 1X/DAY | Y | RX7840927 | 20702 | 20 | MG | FILM-COATED TABLET | QD | |||||
125632523 | 12563252 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Y | 20702 | FILM-COATED TABLET | ||||||||||
125632523 | 12563252 | 3 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Oral | 500MG ONE OR TWO TABLETS, AS NEEDED | 0 | TABLET | |||||||||
125632523 | 12563252 | 4 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | 0 | TABLET | |||||||||||
125632523 | 12563252 | 5 | C | ADVIL | IBUPROFEN | 1 | Oral | 200MG ONE OR TWO TABLETS BY MOUTH TWICE A DAY, AS NEEDED | J25511 | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125632523 | 12563252 | 1 | Blood cholesterol increased |
125632523 | 12563252 | 2 | Hyperlipidaemia |
125632523 | 12563252 | 3 | Arthralgia |
125632523 | 12563252 | 4 | Abdominal pain upper |
125632523 | 12563252 | 5 | Pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125632523 | 12563252 | HO |
125632523 | 12563252 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125632523 | 12563252 | Activities of daily living impaired | |
125632523 | 12563252 | Arthralgia | |
125632523 | 12563252 | Blood creatine phosphokinase increased | |
125632523 | 12563252 | Dermatomyositis | |
125632523 | 12563252 | Fatigue | |
125632523 | 12563252 | Gait disturbance | |
125632523 | 12563252 | Muscle injury | |
125632523 | 12563252 | Muscular weakness | |
125632523 | 12563252 | Myalgia | |
125632523 | 12563252 | Rash | |
125632523 | 12563252 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125632523 | 12563252 | 1 | 20140829 | 0 | ||
125632523 | 12563252 | 3 | 201510 | 0 | ||
125632523 | 12563252 | 5 | 201510 | 0 |